GlaxoSmithKline CEO seeks FDA approval for 'at least' six drugs in 2020
Keep Me Logged In.
GlaxoSmithKline CEO expects to get 'at least' six drug approvals from the FDA in 2020.
GlaxoSmithKline CEO Emma Walmsley told "Mad Money" host Jim Cramer the British drugmaker has received "positive data" for cancer and HIV drugs.
Technician: JPMorgan has looked 'too good' for much too long.
Phase one trade deal expected to be signed on Jan. 15.
S&P 500 and Nasdaq close at record highs.
Watch CNBC's full interview with ImClone Systems founder Sam Waksal.
What investors should know ahead of Big Banks earnings.